- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Fluoroquinolones Linked to Hypo-, Hyperglycemia
Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.
Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.
In a large cohort study, the fluoroquinolones were linked to a heightened risk of both hypo- and hyperglycemia, compared with other antibiotic classes, according to Mei-Shu Lai, MD, PhD, and colleagues at the National Taiwan University in Taipei.
The risks were low -- observed in fewer than one in 100 patients studied -- but clinicians should be cautious when treating diabetic patients with fluoroquinolones, Lai and colleagues reported online in Clinical Infectious Diseases.
"Other antibiotics should be considered if dysglycemia is a concern," Lai and colleagues argued.
Read the full story here: http://bit.ly/1cFRT4B
Source: Med Page Today
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
